177 related articles for article (PubMed ID: 27589870)
1. The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.
West MA; Loughney L; Ambler G; Dimitrov BD; Kelly JJ; Mythen MG; Sturgess R; Calverley PM; Kendrick A; Grocott MP; Jack S
BMC Cancer; 2016 Sep; 16(1):710. PubMed ID: 27589870
[TBL] [Abstract][Full Text] [Related]
2. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial.
Loughney L; West MA; Kemp GJ; Rossiter HB; Burke SM; Cox T; Barben CP; Mythen MG; Calverley P; Palmer DH; Grocott MP; Jack S
Trials; 2016 Jan; 17():24. PubMed ID: 26762365
[TBL] [Abstract][Full Text] [Related]
3. The effects of cancer therapies on physical fitness before oesophagogastric cancer surgery: a prospective, blinded, multi-centre, observational, cohort study.
West MA; Anastasiou Z; Ambler G; Loughney L; Mythen MG; Owen T; Danjoux G; Levett DZH; Calverley PMA; Kelly JJ; Jack S; Grocott MPW;
NIHR Open Res; 2021; 1():1. PubMed ID: 35106479
[TBL] [Abstract][Full Text] [Related]
4. The effect of a pre- and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (The PERIOP-OG Trial): Study protocol for a randomised controlled trial.
Tully R; Loughney L; Bolger J; Sorensen J; McAnena O; Collins CG; Carroll PA; Arumugasamy M; Murphy TJ; Robb WB;
Trials; 2020 Jul; 21(1):638. PubMed ID: 32660526
[TBL] [Abstract][Full Text] [Related]
5. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.
Jack S; West MA; Raw D; Marwood S; Ambler G; Cope TM; Shrotri M; Sturgess RP; Calverley PM; Ottensmeier CH; Grocott MP
Eur J Surg Oncol; 2014 Oct; 40(10):1313-20. PubMed ID: 24731268
[TBL] [Abstract][Full Text] [Related]
6. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
[TBL] [Abstract][Full Text] [Related]
8. The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot study.
West MA; Loughney L; Lythgoe D; Barben CP; Adams VL; Bimson WE; Grocott MP; Jack S; Kemp GJ
PLoS One; 2014; 9(12):e111526. PubMed ID: 25478898
[TBL] [Abstract][Full Text] [Related]
9. The Wessex Fit-4-Cancer Surgery Trial (WesFit): a protocol for a factorial-design, pragmatic randomised-controlled trial investigating the effects of a multi-modal prehabilitation programme in patients undergoing elective major intra-cavity cancer surgery.
West M; Bates A; Grimmett C; Allen C; Green R; Hawkins L; Moyses H; Leggett S; Z H Levett D; Rickard S; Varkonyi-Sepp J; Williams F; Wootton S; Hayes M; P W Grocott M; Jack S
F1000Res; 2021; 10():952. PubMed ID: 36247802
[No Abstract] [Full Text] [Related]
10. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
[TBL] [Abstract][Full Text] [Related]
11. A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
Larue RT; Van De Voorde L; Berbée M; van Elmpt WJ; Dubois LJ; Panth KM; Peeters SG; Claessens A; Schreurs WM; Nap M; Warmerdam FA; Erdkamp FL; Sosef MN; Lambin P
BMC Cancer; 2016 Aug; 16():644. PubMed ID: 27535748
[TBL] [Abstract][Full Text] [Related]
12. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
West MA; Loughney L; Lythgoe D; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Br J Anaesth; 2015 Feb; 114(2):244-51. PubMed ID: 25274049
[TBL] [Abstract][Full Text] [Related]
13. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
[TBL] [Abstract][Full Text] [Related]
14. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocol.
Chmelo J; Phillips AW; Greystoke A; Charman SJ; Avery L; Hallsworth K; Welford J; Sinclair RCF
Pilot Feasibility Stud; 2020; 6():50. PubMed ID: 32346484
[TBL] [Abstract][Full Text] [Related]
16. Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.
O'Neill L; Moran J; Guinan EM; Reynolds JV; Hussey J
J Cancer Surviv; 2018 Aug; 12(4):601-618. PubMed ID: 29796931
[TBL] [Abstract][Full Text] [Related]
17. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial).
Loughney L; West MA; Moyses H; Bates A; Kemp GJ; Hawkins L; Varkonyi-Sepp J; Burke S; Barben CP; Calverley PM; Cox T; Palmer DH; Mythen MG; Grocott MPW; Jack S;
Perioper Med (Lond); 2021 Jun; 10(1):23. PubMed ID: 34154675
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection.
West MA; Baker WC; Rahman S; Munro A; Jack S; Grocott MP; Underwood TJ; Levett DZ;
J Surg Oncol; 2021 Dec; 124(8):1306-1316. PubMed ID: 34463378
[TBL] [Abstract][Full Text] [Related]
19. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Peak Oxygen Uptake in Lung Cancer Subjects With Neoadjuvant Chemotherapy: A Cross-Sectional Study.
Fresard I; Licker M; Adler D; Lovis A; Robert J; Karenovics W; Diaper J; Janssens JP; Triponez F; Lador F; Rochat T; Espinosa V; Bhatia C; Kayser B; Bridevaux PO
Respir Care; 2016 Aug; 61(8):1059-66. PubMed ID: 27165422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
